Dynamic Medical Technologies (4138) — Capital Reinvestment Ratio
Dynamic Medical Technologies (4138) has a Capital Reinvestment Ratio of 0.02x as of December 2025, meaning it reinvests 0% of its operating cash flow (NT$246.38 Million) in capital expenditures (NT$3.73 Million). Check tangible equity quality of Dynamic Medical Technologies to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Dynamic Medical Technologies Capital Reinvestment Ratio (2016–2025)
This chart tracks Dynamic Medical Technologies's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see 4138 cash flow metrics.
Annual Capital Reinvestment Ratio for Dynamic Medical Technologies (2016–2025)
Year-by-year Capital Reinvestment Ratio for Dynamic Medical Technologies from 2016 to 2025. See 4138 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.17x | NT$314.86 Million | NT$52.15 Million | ▼ -62.0% |
| 2024 | 0.44x | NT$224.11 Million | NT$97.58 Million | ▲ +118.9% |
| 2023 | 0.20x | NT$360.95 Million | NT$71.80 Million | ▼ -52.0% |
| 2022 | 0.41x | NT$276.93 Million | NT$114.71 Million | ▲ +171.8% |
| 2021 | 0.15x | NT$277.64 Million | NT$42.31 Million | ▲ +334.3% |
| 2020 | 0.04x | NT$248.55 Million | NT$8.72 Million | ▼ -70.6% |
| 2019 | 0.12x | NT$274.48 Million | NT$32.80 Million | ▲ +10.5% |
| 2018 | 0.11x | NT$147.46 Million | NT$15.96 Million | ▼ -38.3% |
| 2017 | 0.18x | NT$145.18 Million | NT$25.46 Million | ▲ +172.7% |
| 2016 | 0.06x | NT$250.35 Million | NT$16.10 Million | — |